Biolife Solutions (BLFS) EBITDA Margin (2010 - 2026)
Biolife Solutions (BLFS) reported EBITDA Margin of 0.1% for Q1 2026, up 236.0% year-over-year from 0.03% in Q1 2025, and down 98.63% on a QoQ basis from 7.17% in Q4 2025.
Biolife Solutions (BLFS) has 17 years of EBITDA Margin data on file, last reported at 0.1% in Q1 2026.
- Quarterly EBITDA Margin rose 236.0% year-over-year to 0.1% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 15.39% (down 1325.0% YoY) and the FY2025 annual result came in at 17.26%, down 1126.0% from the prior year.
- EBITDA Margin eased to 0.1% in Q1 2026 per BLFS's latest filing, from 7.17% in the prior quarter.
- Across five years, EBITDA Margin topped out at 7.17% in Q4 2025 and bottomed at 218.96% in Q4 2022.
- The 5-year median for EBITDA Margin is 22.0% (2022), against an average of 47.4%.
- The widest annual swing landed in 2022, when EBITDA Margin tumbled 17429 bps; it then soared 15254 bps in 2023.
- Tracing BLFS's EBITDA Margin over 5 years: stood at 218.96% in 2022, then surged by 43 bps to 125.43% in 2023, then soared by 103 bps to 3.59% in 2024, then soared by 100 bps to 7.17% in 2025, then sank by 99 bps to 0.1% in 2026.
- Per Business Quant, the three latest BLFS EBITDA Margin figures stand at 0.1% (Q1 2026), 7.17% (Q4 2025), and 0.32% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 28.86% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 1.97% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 34.92% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 20.96% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 4.04% |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 19.85% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 13.65% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 2.44% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 17.48% |
| 10 | Biolife Solutions | 1.20 Bn | 1.12 Bn | 17.50 Mn | 0.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.10% |
| Dec 31, 2025 | 7.17% |
| Sep 30, 2025 | -0.32% |
| Jun 30, 2025 | -65.47% |
| Mar 31, 2025 | -2.26% |
| Dec 31, 2024 | 3.59% |
| Sep 30, 2024 | -1.95% |
| Jun 30, 2024 | -6.62% |
| Mar 31, 2024 | -17.88% |
| Dec 31, 2023 | -125.43% |
| Sep 30, 2023 | -65.65% |
| Jun 30, 2023 | -36.35% |
| Mar 31, 2023 | -36.08% |
| Dec 31, 2022 | -218.96% |
| Sep 30, 2022 | -28.81% |
| Jun 30, 2022 | -188.89% |
| Mar 31, 2022 | -22.00% |
| Dec 31, 2021 | -49.50% |
| Sep 30, 2021 | -33.01% |
| Jun 30, 2021 | -14.60% |
| Mar 31, 2021 | -5.82% |
| Dec 31, 2020 | -36.73% |
| Sep 30, 2020 | -11.05% |
| Jun 30, 2020 | 0.44% |
| Mar 31, 2020 | 3.04% |
| Dec 31, 2019 | -9.17% |
| Sep 30, 2019 | -11.69% |
| Jun 30, 2019 | 11.15% |
| Dec 31, 2018 | 19.12% |
| Sep 30, 2018 | 22.58% |
| Jun 30, 2018 | 24.82% |
| Dec 31, 2017 | -0.56% |
| Sep 30, 2017 | -1.09% |
| Jun 30, 2017 | -13.34% |
| Mar 31, 2017 | -19.61% |
| Dec 31, 2016 | -27.89% |
| Sep 30, 2016 | -53.29% |
| Jun 30, 2016 | -80.10% |
| Mar 31, 2016 | -80.58% |
| Dec 31, 2015 | -77.18% |
| Sep 30, 2015 | -79.44% |
| Jun 30, 2015 | -66.46% |
| Mar 31, 2015 | -77.33% |
| Sep 30, 2014 | -69.29% |
| Mar 31, 2014 | -17.87% |
| Mar 31, 2013 | 8.90% |
| Dec 31, 2012 | -15.06% |
| Sep 30, 2012 | -8.87% |
| Jun 30, 2012 | -28.07% |
| Mar 31, 2012 | -3,585.28% |
| Dec 31, 2011 | -26.17% |
| Sep 30, 2011 | -40.08% |
| Jun 30, 2011 | -41.75% |
| Mar 31, 2011 | -74.37% |
| Dec 31, 2010 | 21.44% |
| Sep 30, 2010 | -55.05% |
| Jun 30, 2010 | -7,830.54% |